Friday 29th January 2021
Russia wants to help out with Sputnik V.
Astrazeneca’s delayed vaccine delivery threatens to thwart the EU’s vaccination schedule. Now the Russian manufacturer of Sputnik V is offering to make 100 million cans available by the summer. To do this, the active ingredient would first have to be approved.
In the dispute over the scarce corona vaccine from the manufacturer Astrazeneca for the European Union, Russia wants to help out with its vaccine. In the second quarter, 100 million doses of the Sputnik V vaccine could be delivered, announced the state direct investment fund in Moscow, which co-finances the vaccine and markets it abroad. This would allow 50 million people to be vaccinated.
The prerequisite for this is that the European Medicines Agency (EMA) approves the active ingredient. A corresponding application was submitted last week. At the federal press conference, the President of the Paul Ehrlich Institute, Klaus Cichutek, did not rule out the approval of Sputnik V. The institute had “already advised the Russian colleagues on regulatory issues”. However, it must be ensured that the data situation meets the requirements of the licensing authorities.
According to the fund, delivery to the EU would be possible once a large part of the mass vaccination in Russia is completed. The vaccinations have been running since December. According to the latest figures, more than 1.5 million people have received the two-component vaccine. According to the information, Sputnik V is now registered in 15 countries. Last week, Hungary was the first EU country to order two million doses of the Russian preparation.
The active ingredient was the first in the world to be approved for broad use in the population in mid-August, although important tests had passed by then. This triggered international criticism. No independent studies are known to date. The British-Swedish pharmaceutical company Astrazeneca is struggling with production problems.